The antibody isotyping market is likely to attain 11% CAGR during the forecast period 2022-2032.
Antibody isotyping kits are used to determine the class of monoclonal antibodies and it is performed for better characterization of antibodies which is in high demand in the recent times resulting in rising sales of antibody isotyping kits.
Attributes | Details |
Antibody Isotyping Kits Market CAGR | 11% |
Antibody Isotyping Kits Market Value (2022) | US$ 145 Bn |
Higher demand for antibody isotyping kits can be attributed to its efficiency in detecting and diagnosing various infections including dengue, HIV, influenza, Ebola and hepatitis.
In addition, sales of antibody isotyping is expected to rise as it gives information related to immune response after infection, vaccination and drug therapy.
Increased prevalence of various disease is projected to create a conducive environment for the growing demand for antibody isotyping kits worldwide in near future.
Certain technological advances make antibody isotyping kits more convenient and easier to use and, in turn, propelling the demand for antibody isotyping kits as well as sales of antibody isotyping kits.
In April 2019, Bio-Rad introduced isotype specific secondary antibodies in a global antibody isotyping market.
The demand for antibody isotyping kits is expected to surge as these antibodies can improve positive signals by eliminating possibilities of false positive or negative results and it also having the less cross reactivity.
As a result of this, the competition between the other key players is significantly increased vying for a larger chunk of antibody isotyping kits market share.
The report sheds light on the factors improving the sales of antibody isotyping kits, and, in turn, the opportunities for the market players for enlarging their antibody isotyping kits market share.
However, the antibody isotyping kits market also faces some challenges, which might limit the demand for antibody isotyping kits from reaching its potential.
Increasing incidence of infectious disease and increased use of antibody isotyping in oncology are the factors propelling the demand for antibody isotyping kits around the globe.
As stated by the Centres for Disease Control and Prevention (CDC), globally 10 million cases of tuberculosis were registered and about 1.3 million deaths were caused by the same in 2017.
Additionally, technological advancements by key players, increased sensitivity as well as cost effectiveness of antibody isotyping kits supplement the sales of antibody isotyping kits in coming years.
Furthermore, increased age makes person more prone to the infection hence, increased geriatric population act as a key factor to drive the demand for antibody isotyping kits.
Soaring sales of antibody isotyping kits can also be attributed to the expanding biotechnology and pharmaceutical industries and increased academic research activity.
However, low detection limit, complex regulatory framework for approval of new product and implementation of excise duty by US government on antibody isotyping kits are likely to impede the demand for antibody isotyping kits and in turn, sales of antibody isotyping kits.
The global market for antibody isotyping kits is marked by presence of various small-scale manufacturers but the market is dominated by major key players like Thermo Fisher Scientific and Roche diagnostics.
The antibody isotyping kits market is competitive in nature on account of major key players implementing new strategies like partnerships, regional expansion to increase their antibody isotyping kits market share.
ELISA antibody isotyping kits holding the largest antibody isotyping kits markets share in on account of its increased popularity over the years as it is capable to detect various food allergies, viral infections such as HIV and influenza.
Increased prevalence of these diseases is expected to trigger the demand for antibody isotyping kits during forecast period.
The report consists of key players, contributing to the antibody isotyping kits market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions.
This exclusive report analysis the competitive landscape and antibody isotyping kits market share acquired by players to strengthen their market position.
Globally, Antibody Isotyping Kits market divided into following region- Latin America, North America, Europe, Asia-Pacific, Japan and Africa (MEA).
North America is expected to account for the highest sales of antibody isotyping kits globally due to well-developed healthcare infrastructure, increasing use of immunoassay in clinical diagnostics and significant product penetration.
Additionally high investment into research and development activities by key players is likely to propel the demand for antibody isotyping kits.
Increased funds by government are also anticipated to drive the overall sales of antibody isotyping kits during forecast period.
Asia specific is also experiencing significant growth in sales of antibody isotyping kits due to increased healthcare spending in emerging economies like India, South Korea and China.
Report Attribute | Details |
Base year for estimation | 2021 |
Historical data | 2015 - 2021 |
Forecast period | 2022 - 2032 |
Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
Key companies profiled | Ortho Clinical and Siemens, Thermo Fisher Scientific, BD, Abbott, Roche, Danaher, Bio-Rad, BioMérieux, and others. |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
North America is likely to account for the highest antibody isotyping kits market share owing to well-developed healthcare infrastructure, increasing use of immunoassay in clinical diagnostics, etc.
The antibody isotyping kits market is fairly competitive in nature as major key players implement new strategies like partnerships, regional expansion, etc.
The antibody isotyping kits market is dominated by major key players like Thermo Fisher Scientific and Roche diagnostics.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.